| Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis V Farrokhi, R Nemati, FC Nichols, X Yao, E Anstadt, M Fujiwara, J Grady, ... Clinical & Translational Immunology, npg 2 (11), e8, 2013 | 103 | 2013 |
| Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands RB Clark, JL Cervantes, MW Maciejewski, V Farrokhi, R Nemati, X Yao, ... Infection and immunity 81 (9), 3479-3489, 2013 | 84 | 2013 |
| 2019 white paper on recent issues in bioanalysis: FDA immunogenicity guidance, gene therapy, critical reagents, biomarkers and flow cytometry validation (part 3–recommendations … S Piccoli, D Mehta, A Vitaliti, J Allinson, S Amur, S Eck, C Green, ... Bioanalysis 11 (24), 2207-2244, 2019 | 81 | 2019 |
| Development of fast Fourier transformations with continuous cyclic voltammetry at an Au microelectrode and its application for the sub nano-molar monitoring of methyl morphine … MR Ganjali, P Norouzi, R Dinarvand, R Farrokhi, AA Moosavi-Movahedi Materials Science and Engineering: C 28 (8), 1311-1318, 2008 | 52 | 2008 |
| Human FcRn tissue expression profile and half-life in PBMCs YY Fan, V Farrokhi, T Caiazzo, M Wang, DM O’Hara, H Neubert Biomolecules 9 (8), 373, 2019 | 37 | 2019 |
| Assessing the feasibility of neutralizing osteopontin with various therapeutic antibody modalities V Farrokhi, JR Chabot, H Neubert, Z Yang Scientific reports 8 (1), 1-7, 2018 | 33 | 2018 |
| Protein turnover measurements in human serum by serial immunoaffinity LC-MS/MS V Farrokhi, X Chen, H Neubert Clinical chemistry 64 (2), 279-288, 2018 | 17 | 2018 |
| Development of structural marker peptides for cystic fibrosis transmembrane conductance regulator in cell plasma membrane by reversed-footprinting mass spectrometry V Farrokhi, B Bajrami, R Nemati, AJ McShane, F Rueckert, B Wells, X Yao Analytical chemistry 87 (17), 8603-8607, 2015 | 16 | 2015 |
| Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy V Farrokhi, J Walsh, J Palandra, J Brodfuehrer, T Caiazzo, J Owens, ... Gene therapy 29 (10), 608-615, 2022 | 15 | 2022 |
| Measuring the Turnover Rate of Clinically Important Plasma Proteins using an Automated SISCAPA Workflow M Razavi*, V Farrokhi*, R Yip, NL Anderson, TW Pearson, H Neubert Clinical chemistry 65 (3), 492-494, 2019 | 15 | 2019 |
| Targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane AJ McShane, B Bajrami, AA Ramos, PA Diego-Limpin, V Farrokhi, ... Journal of Proteome Research 13 (11), 4676-4685, 2014 | 15 | 2014 |
| Mixed micellar nanoparticles based on PCL-PEG-PPO-PEG-PCL pentablocks S Hassanzadeh, S Khoee, V Farrokhi, M Mahdavi, A Foroumadi Journal of Polymer Research 21, 1-12, 2014 | 9 | 2014 |
| Back to deuterium: utility of 2H-labeled peptides for targeted quantitative proteomics B Bajrami, V Farrokhi, M Zhang, A Shehu, X Yao International Journal of Mass Spectrometry 312, 17-23, 2012 | 9 | 2012 |
| Lanthanide recognition: determination of thulium (III) ions in presence of other rare earth elements by a thulium (III) sensor based on 4-methyl-1, 2-bis (2-pyridinecarboxamido … MR Ganjali, P Norouzi, R Farrokhi, F Faridbod, B Larijani, S Meghdadi Analytical letters 41 (13), 2322-2343, 2008 | 8 | 2008 |
| Scaling proteome-wide reactions of activity-based probes S Li, PA Diego-Limpin, B Bajrami, S Keshipeddy, YW Lam, B Deng, ... Analytical chemistry 89 (12), 6295-6299, 2017 | 7 | 2017 |
| A mechanistic site-of-action model: A tool for informing right target, right compound, and right dose for therapeutic antagonistic antibody programs GI Kapitanov, JR Chabot, J Narula, M Roy, H Neubert, J Palandra, ... Frontiers in Bioinformatics 1, 731340, 2021 | 4 | 2021 |
| Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease X Chen, V Farrokhi, P Singh, MF Ocana, J Patel, LL Lin, H Neubert, ... MAbs 10 (1), 62-70, 2018 | 4 | 2018 |
| Stable isotope dilution mass spectrometry for membrane transporter quantitation V Farrokhi, AJ McShane, R Nemati, X Yao The AAPS journal 15, 1222-1231, 2013 | 3 | 2013 |
| An Overview of Quantitative Proteomic Approaches AJ McShane, V Farrokhi, R Nemati, S Li, X Yao Fundamentals of Advanced Omics Technologies: From Genes to Metabolites 63, 111, 2014 | 2 | 2014 |
| Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy C Le Guiner, X Xiao, T Larcher, A Lafoux, C Huchet, G Toumaniantz, ... Molecular Therapy Methods & Clinical Development 30, 30-47, 2023 | 1 | 2023 |
Xudong YaoDepartment of Chemistry, University of Connecticut, USA在 uconn.edu 的电子邮件经过验证
